Instituto CAICI - Rosario, Santa Fe

Instituto CAICI - Rosario, Santa Fe
Mendoza 2612, Rosario, Santa Fe
Select an option

Our team

Medical staff
SubinvestigadorBrian Abdala
Fedra Boretto
Cristina Ana Maria Guffanti
Bruno Barthe
Alejandra Benz
Nicolas Chichizola
Romina Renzi
PIDiego Viola
Juan Loureyro
Daniel Alberto Siri
Pablo Crema
Juan Carlos Crema
Norberto Javier Quagliato
Carolina Irma Dieguez
Silvana Mariela Conti
Roxana Dotto
Rosana Coronel
Su investigadorMaría Verónica Ochoa y Gómez

Open studies

Arthritis
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) - I4V-MC-JAHU - Eli Lilly and CompanySee more
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis - JUVE-X - Eli Lilly and CompanySee more
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis. - SELECT-sJIA - AbbVieSee more
Heart failure
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure - EASi-HF - Boehringer IngelheimSee more
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity - MARITIME-HF - AmgenSee more
Lupus
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus - AMETHYST - BiogenSee more
Hiv
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1 - CROWN - ViiV HealthcareSee more
Obesity
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity - MARITIME-HF - AmgenSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy